Novus Therapeutics, Inc. (NVUS:NASDAQ) rocketted at $0.89, representing a gain of 29%. On Tue 12 May 20, NVUS:NASDAQ touched a New 2-Week Intraday High of $0.74. From Tue 28 Apr 20, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Novus Therapeutics, Inc. (NVUS:NASDAQ)
Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.
Top 10 Gainers:
- SIFCO Industries, Inc. (SIF:NYSEMKT), 87.97%
- Genius Brands International, Inc. (GNUS:NASDAQ), 79.85%
- United Natural Foods, Inc. (UNFI:NYSE), 45.65%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 37.85%
- Energy Focus, Inc. (EFOI:NASDAQ), 37.62%
- Aviat Networks, Inc. (AVNW:NASDAQ), 31.42%
- Servotronics, Inc. (SVT:NYSEMKT), 29.69%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 28.99%
- Progyny, Inc. (PGNY:NASDAQ), 27.53%
- PGT Innovations, Inc. (PGTI:NYSE), 26.41%